US Stock MarketDetailed Quotes

VANIW VIVANI MEDICAL INC C/WTS 14/03/2024 (TO PUR COM)

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Aug 23 09:30 ET
0Market Cap0.00P/E (TTM)

VIVANI MEDICAL INC C/WTS 14/03/2024 (TO PUR COM) Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
(FY)Dec 31, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
Total revenue
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
4.09M
31.33%3.91M
44.14%13.32M
2.98M
9.24M
Selling and administrative expenses
--884K
115.82%1.23M
-2.40%2.32M
--569K
--2.38M
-General and administrative expense
--884K
115.82%1.23M
-2.40%2.32M
--569K
--2.38M
Research and development costs
--3.2M
11.35%2.68M
60.26%11M
--2.41M
--6.87M
Operating profit
-4.09M
-31.33%-3.91M
-44.14%-13.32M
-2.98M
-9.24M
Net non-operating interest income expense
Other net income (expense)
-16K
-41.67%-17K
1,627.78%550K
-12K
-36K
Special income (charges)
--0
----
--641K
----
--0
-Less:Other special charges
----
----
---641K
----
----
Other non- operating income (expenses)
---16K
-41.67%-17K
-152.78%-91K
---12K
---36K
Income before tax
-4.1M
-31.37%-3.92M
-37.65%-12.77M
-2.99M
-9.28M
Income tax
Net income
-4.1M
-31.37%-3.92M
-37.65%-12.77M
-2.99M
-9.28M
Net income continuous Operations
---4.1M
-31.37%-3.92M
-37.65%-12.77M
---2.99M
---9.28M
Minority interest income
Net income attributable to the parent company
-4.1M
-31.37%-3.92M
-37.65%-12.77M
-2.99M
-9.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-4.1M
-31.37%-3.92M
-37.65%-12.77M
-2.99M
-9.28M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q2)Jun 30, 2022(Q1)Mar 31, 2022(FY)Dec 31, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020
Total revenue 00000
Operating revenue --0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 4.09M31.33%3.91M44.14%13.32M2.98M9.24M
Selling and administrative expenses --884K115.82%1.23M-2.40%2.32M--569K--2.38M
-General and administrative expense --884K115.82%1.23M-2.40%2.32M--569K--2.38M
Research and development costs --3.2M11.35%2.68M60.26%11M--2.41M--6.87M
Operating profit -4.09M-31.33%-3.91M-44.14%-13.32M-2.98M-9.24M
Net non-operating interest income expense
Other net income (expense) -16K-41.67%-17K1,627.78%550K-12K-36K
Special income (charges) --0------641K------0
-Less:Other special charges -----------641K--------
Other non- operating income (expenses) ---16K-41.67%-17K-152.78%-91K---12K---36K
Income before tax -4.1M-31.37%-3.92M-37.65%-12.77M-2.99M-9.28M
Income tax
Net income -4.1M-31.37%-3.92M-37.65%-12.77M-2.99M-9.28M
Net income continuous Operations ---4.1M-31.37%-3.92M-37.65%-12.77M---2.99M---9.28M
Minority interest income
Net income attributable to the parent company -4.1M-31.37%-3.92M-37.65%-12.77M-2.99M-9.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -4.1M-31.37%-3.92M-37.65%-12.77M-2.99M-9.28M
Basic earnings per share
Diluted earnings per share
Dividend per share
Currency Unit USDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg